scispace - formally typeset
K

Kanchan Hajela

Researcher at Central Drug Research Institute

Publications -  44
Citations -  711

Kanchan Hajela is an academic researcher from Central Drug Research Institute. The author has contributed to research in topics: Apoptosis & Cell growth. The author has an hindex of 15, co-authored 44 publications receiving 599 citations. Previous affiliations of Kanchan Hajela include Academy of Scientific and Innovative Research.

Papers
More filters
Journal ArticleDOI

Synthesis and biological activities of some new dibenzopyranones and dibenzopyrans: search for potential oestrogen receptor agonists and antagonists

TL;DR: Some new tricyclic molecules bridged between the active molecules of 3,4-Diaryl chroman and 2,3-diaryl benzopyrans have been synthesised to search for newer oestrogen agonists or antagonists.
Journal ArticleDOI

Synthesis and biological evaluation of 3,4,6-triaryl-2-pyranones as a potential new class of anti-breast cancer agents.

TL;DR: A series of 3,4,6-triaryl-2-pyranones, new class of anti-breast cancer agents, have been synthesized as a structural variants of cyclic triphenylethylenes by replacing the fused benzene ring with pendant phenyl ring to mimic the phenolic A ring of estradiol.
Journal ArticleDOI

Design and synthesis of ERα/ERβ selective coumarin and chromene derivatives as potential anti-breast cancer and anti-osteoporotic agents

TL;DR: Several new coumarin and chromene prototype derivatives have been synthesised and evaluated for their ERα and ERβ selective activity, and the surprise finding of the series are the novel prototype III chromenes 45 & 46, with aroyl substitution at the 6th position.
Journal ArticleDOI

NAD+-dependent DNA ligase (Rv3014c) from Mycobacterium tuberculosis: novel structure-function relationship and identification of a specific inhibitor.

TL;DR: In silico ligand‐docking studies suggest that the exquisite specificity of the inhibitor arises on account of its mimicking the interactions of NAD+ with MtuLigA, and an analysis of conserved water in the binding site of the enzyme suggests strategies for synthesis of improved inhibitors with better specificity and potency.
Journal ArticleDOI

Tandem C-2 functionalization-intramolecular azide-alkyne 1,3-dipolar cycloaddition reaction: a convenient route to highly diversified 9H-benzo[b]pyrrolo[1,2-g][1,2,3]triazolo[1,5-d][1,4]diazepines.

TL;DR: The reaction shows high substrate tolerance and provides a library of fused heterocycles that may lead to novel biologically active compounds or drug lead molecules.